Cargando…
In Vitro and Clinical Evaluations of the Drug-Drug Interaction Potential of a Metabotropic Glutamate 2/3 Receptor Agonist Prodrug with Intestinal Peptide Transporter 1
Despite peptide transporter 1 (PEPT1) being responsible for the bioavailability for a variety of drugs, there has been little study of its potential involvement in drug-drug interactions. Pomaglumetad methionil, a metabotropic glutamate 2/3 receptor agonist prodrug, utilizes PEPT1 to enhance absorpt...
Autores principales: | Pak, Y. Anne, Long, Amanda J., Annes, William F., Witcher, Jennifer W., Knadler, Mary Pat, Ayan-Oshodi, Mosun A., Mitchell, Malcolm I., Leese, Phillip, Hillgren, Kathleen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Pharmacology and Experimental Therapeutics
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5267515/ https://www.ncbi.nlm.nih.gov/pubmed/27895114 http://dx.doi.org/10.1124/dmd.116.071118 |
Ejemplares similares
-
Metabotropic Glutamate Receptors: Potential Drug Targets for Psychiatric Disorders
por: Yasuhara, Akito, et al.
Publicado: (2010) -
Computational Drug Design Applied to the Study of Metabotropic Glutamate Receptors
por: Llinas del Torrent, Claudia, et al.
Publicado: (2019) -
Safety and pharmacokinetic profiles of MGS0274 besylate (TS‐134), a novel metabotropic glutamate 2/3 receptor agonist prodrug, in healthy subjects
por: Watanabe, Mai, et al.
Publicado: (2020) -
Preclinical disposition of MGS0274 besylate, a prodrug of a potent group II metabotropic glutamate receptor agonist MGS0008 for the treatment of schizophrenia
por: Kinoshita, Kohnosuke, et al.
Publicado: (2019) -
Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Drugs
por: Muguruza, Carolina, et al.
Publicado: (2016)